Elanco Animal Health (ELAN) Net Income Growth (3y) (2020 - 2026)
Elanco Animal Health (ELAN) Net Income Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 51.28% |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 2.94% |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -62.58% |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 4.50% |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -7.75% |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 66.11% |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | -17.90% |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | -38.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.90% |
| Dec 31, 2025 | -72.25% |
| Sep 30, 2025 | 19.43% |
| Jun 30, 2025 | 45.81% |
| Mar 31, 2025 | 9.52% |
| Dec 31, 2024 | 57.61% |
| Sep 30, 2024 | 75.12% |
| Jun 30, 2024 | 37.62% |
| Mar 31, 2024 | 35.72% |
| Dec 31, 2023 | 24.13% |
| Sep 30, 2023 | -100.98% |
| Jun 30, 2023 | -22.32% |
| Mar 31, 2023 | 60.08% |
| Dec 31, 2022 | -78.47% |
| Sep 30, 2022 | -104.08% |
| Jun 30, 2022 | -31.59% |
| Mar 31, 2022 | 17.42% |
| Dec 31, 2021 | -103.30% |
| Sep 30, 2021 | -55.97% |
| Jun 30, 2021 | -48.58% |